Literature DB >> 27979354

Alzheimer's disease and other dementias: update on research.

Lon Schneider1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 27979354     DOI: 10.1016/S1474-4422(16)30356-8

Source DB:  PubMed          Journal:  Lancet Neurol        ISSN: 1474-4422            Impact factor:   44.182


× No keyword cloud information.
  6 in total

1.  Neuroprotective Effects and Mechanism of β-Asarone against Aβ1-42-Induced Injury in Astrocytes.

Authors:  Yuanxiao Yang; Ling Xuan; Hongshu Chen; Shijie Dai; Liting Ji; Yuting Bao; Changyu Li
Journal:  Evid Based Complement Alternat Med       Date:  2017-11-28       Impact factor: 2.629

2.  Network analysis of canine brain morphometry links tumour risk to oestrogen deficiency and accelerated brain ageing.

Authors:  Nina M Rzechorzek; Olivia M Saunders; Lucy V Hiscox; Tobias Schwarz; Katia Marioni-Henry; David J Argyle; Jeffrey J Schoenebeck; Tom C Freeman
Journal:  Sci Rep       Date:  2019-08-29       Impact factor: 4.379

Review 3.  Amyloid-β: a potential link between epilepsy and cognitive decline.

Authors:  Michele Romoli; Arjune Sen; Lucilla Parnetti; Paolo Calabresi; Cinzia Costa
Journal:  Nat Rev Neurol       Date:  2021-06-11       Impact factor: 42.937

4.  Machine Learning and Novel Biomarkers for the Diagnosis of Alzheimer's Disease.

Authors:  Chun-Hung Chang; Chieh-Hsin Lin; Hsien-Yuan Lane
Journal:  Int J Mol Sci       Date:  2021-03-09       Impact factor: 5.923

Review 5.  Neurodegenerative Diseases: Regenerative Mechanisms and Novel Therapeutic Approaches.

Authors:  Rashad Hussain; Hira Zubair; Sarah Pursell; Muhammad Shahab
Journal:  Brain Sci       Date:  2018-09-15

6.  Application of modern neuroimaging technology in the diagnosis and study of Alzheimer's disease.

Authors:  Hong-Mei Zeng; Hua-Bo Han; Qi-Fang Zhang; Hua Bai
Journal:  Neural Regen Res       Date:  2021-01       Impact factor: 5.135

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.